Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2017 Oct 19;7:13532. doi: 10.1038/s41598-017-13206-5

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2017

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

PMC Copyright notice

Effects of pharmacological intervention on the renal cortical expression of Nrf-2, GCLC and HO-1. Western blot analysis of Nrf2 expression in nuclear (A), Nrf2 in whole cell lysate fractions (B), GCLC (C), and HO-1 (D) of renal cortical tissues (whole cell lysate fraction) (cropped blots) normalized to β-actin. Lamin B1 was used as a marker for the nuclear fraction. Full-length blots are presented in Supplementary Figure 3. Bar graphs presented show mean ± SEM. n = 6 rats per group. C - control group; DM - diabetic group; DMI - diabetic plus insulin group; DMIS - diabetic and insulin plus atorvastatin group; DMS - diabetic plus atorvastatin group; CS - control plus atorvastatin. *p < 0.05 vs. control group and control plus atorvastatin groups, ^†p < 0.05 vs. diabetic group, ^‡p < 0.05 vs. diabetic plus insulin group, and ^#p < 0.05 vs. diabetic plus atorvastatin group.